Aquestive Therapeutics Inc

Aquestive Therapeutics Inc

AQST

Market Cap$339.7M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aquestive Therapeutics IncAquestive Therapeutics Inc-6-89%--0.9
$7.00

Target Price by Analysts

104.7% upsideAquestive Therapeutics Target Price DetailsTarget Price
$-2.52

Current Fair Value

173.8% downside

Overvalued by 173.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$339.70 Million
Enterprise Value$323.51 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.51
Beta1.93
Outstanding Shares95,497,056

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-6.02
PEG-7.65
Price to Sales-
Price to Book Ratio-3.42
Enterprise Value to Revenue5.97
Enterprise Value to EBIT-8.14
Enterprise Value to Net Income-6
Total Debt to Enterprise0.16
Debt to Equity-0.86

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Aquestive Therapeutics Inc